These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2944909)

  • 21. Heterogeneity of prostaglandin H2/thromboxane A2 receptors: distinct subtypes mediate vascular smooth muscle contraction and platelet aggregation.
    Furci L; Fitzgerald DJ; Fitzgerald GA
    J Pharmacol Exp Ther; 1991 Jul; 258(1):74-81. PubMed ID: 1830100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beneficial effects of thromboxane receptor antagonists in acute cardiovascular crises.
    Lefer AM
    Prog Clin Biol Res; 1987; 242():221-8. PubMed ID: 2959963
    [No Abstract]   [Full Text] [Related]  

  • 23. Capillary gas chromatographic method for the determination of the thromboxane A2 receptor antagonist S-1452 and its metabolites in human urine.
    Okamoto J; Hirai E; Suzuki Y; Fujimoto K; Kitagawa T; Matsubara T
    J Chromatogr; 1992 Nov; 583(1):53-62. PubMed ID: 1484092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eicosapentaenoic acid and docosahexaenoic acid are antagonists at the thromboxane A2/prostaglandin H2 receptor in human platelets.
    Swann PG; Venton DL; Le Breton GC
    FEBS Lett; 1989 Jan; 243(2):244-6. PubMed ID: 2537230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ICI 180080, a novel selective thromboxane receptor antagonist: synthesis and relative activity.
    Brown GR; Foubister AJ
    J Pharm Pharmacol; 1986 Sep; 38(9):706-8. PubMed ID: 2877076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 7-[(1R,2S,3S,5R)-6,6-dimethyl-3-(4- iodobenzenesulfonylamino)bicyclo[3.1.1]hept-2-yl]-5(Z)-heptenoic acid: a novel high-affinity radiolabeled antagonist for platelet thromboxane A2/prostaglandin H2 receptors.
    Naka M; Mais DE; Morinelli TA; Hamanaka N; Oatis JE; Halushka PV
    J Pharmacol Exp Ther; 1992 Aug; 262(2):632-7. PubMed ID: 1386885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thromboxane A2 receptor characterization in human astrocytoma cells and rabbit platelets by a new thromboxane antagonist, [3H]ONO NT-126.
    Takano S; Ishimoto H; Nakahata N; Nakanishi H
    Res Commun Chem Pathol Pharmacol; 1992 May; 76(2):155-70. PubMed ID: 1534919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of thromboxane A2.
    Ambler J; Birch J; Maguire ED; Wallis RB
    Adv Exp Med Biol; 1985; 192():293-308. PubMed ID: 2939695
    [No Abstract]   [Full Text] [Related]  

  • 29. Binding characteristics of the new thromboxane A2/prostaglandin H2 receptor antagonist [3H]BAY U 3405 to washed human platelets and platelet membranes.
    Theis JG; Dellweg H; Perzborn E; Gross R
    Biochem Pharmacol; 1992 Aug; 44(3):495-503. PubMed ID: 1387312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Agonist-induced phosphorylation of human platelet TXA2/PGH2 receptors.
    Okwu AK; Mais DE; Halushka PV
    Biochim Biophys Acta; 1994 Mar; 1221(1):83-8. PubMed ID: 8130280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 7-Oxabicyclo[2.2.1]heptane analogs as modulators of the thromboxane A2 and prostacyclin receptors.
    Sprague PW; Heikes JE; Harris DN; Greenberg R
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():337-43. PubMed ID: 6303073
    [No Abstract]   [Full Text] [Related]  

  • 32. Activity of the short-acting thromboxane receptor antagonist, SQ 30,741, in thrombolytic and vasospastic models in monkeys.
    Schumacher WA; Heran CL; Hartl KS; Ogletree ML
    J Pharmacol Exp Ther; 1990 May; 253(2):841-6. PubMed ID: 2140131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human erythroleukemia cells express functional thromboxane A2/prostaglandin H2 receptors.
    Mayeux PR; Mais DE; Carr C; Halushka PV
    J Pharmacol Exp Ther; 1989 Sep; 250(3):923-7. PubMed ID: 2528631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of acute myocardial ischaemia with a selective antagonist of thromboxane receptors (BM 13.177).
    Schrör K; Thiemermann C
    Br J Pharmacol; 1986 Apr; 87(4):631-7. PubMed ID: 3011166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Labeling of human platelet plasma membrane thromboxane A2/prostaglandin H2 receptors using SQB, a novel biotinylated receptor probe.
    Komiotis D; Wencel-Drake JD; Dieter JP; Lim CT; Le Breton GC
    Biochem Pharmacol; 1996 Sep; 52(5):763-70. PubMed ID: 8765474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AH23848: a thromboxane receptor-blocking drug that can clarify the pathophysiologic role of thromboxane A2.
    Brittain RT; Boutal L; Carter MC; Coleman RA; Collington EW; Geisow HP; Hallett P; Hornby EJ; Humphrey PP; Jack D
    Circulation; 1985 Dec; 72(6):1208-18. PubMed ID: 2998642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet and vascular smooth muscle thromboxane A2/prostaglandin H2 receptors.
    Halushka PV; Mais DE; Saussy DL
    Fed Proc; 1987 Jan; 46(1):149-53. PubMed ID: 2948839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet thromboxane A2/prostaglandin H2 receptors in human volunteers on low doses of aspirin.
    Covatto RH; Niewiarowski S
    Biochem Pharmacol; 1990 Oct; 40(7):1559-61. PubMed ID: 2145839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitory effect of a selective thromboxane A2 receptor antagonist, EP 092, on platelet aggregation in whole blood ex vivo and in vivo.
    Booth RF; Honey AC; Lad N; Tuffin DP; Wade PJ
    Br J Pharmacol; 1989 Feb; 96(2):395-405. PubMed ID: 2522336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective effects of ONO 3708, a new thromboxane A2 receptor antagonist, during experimental endotoxin shock.
    Taneyama C; Sasao J; Senna S; Kimura M; Kiyono S; Goto H; Arakawa K
    Circ Shock; 1989 May; 28(1):69-77. PubMed ID: 2525079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.